Sign inGet started

Friedman Charlene A

Insider CIK 1413748 · MAPP SVP, Gen Counsel & Sec

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0455,000— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-044,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0432,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0427,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-048,250— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0450,805— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0430,000— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0474,744— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. U Tender2013-03-012013-03-044,229$25.00 $105.7K0SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-262013-01-292,250— $04,500SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2013-01-262013-01-29871$24.75 $21.6K4,229SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-262013-01-292,250— $05,100SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-252013-01-292,750— $08,250SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2013-01-252013-01-291,207$24.75 $29.9K2,850SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-252013-01-292,750— $04,057SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2012-03-092012-03-1310,000— $022,328SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2012-03-092012-03-1310,000$17.50 $175.0K1,307SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2012-03-092012-03-1310,000$12.37 $123.7K11,307SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2012-01-262012-01-272,250— $06,750SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2012-01-262012-01-27943$13.84 $13.1K1,307SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2012-01-262012-01-272,250— $02,250SEC↗
MAPP MAP Pharmaceuticals, Inc. A Award deriv2012-01-252012-01-2732,500— $032,500SEC↗
MAPP MAP Pharmaceuticals, Inc. A Award deriv2012-01-252012-01-2711,000— $011,000SEC↗